Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Alexion Pharmaceutical Inc. buy melinda

Start price
€125.50
29.09.18
Target price
€130.79
Performance (%)
-43.827%
End price
€70.50
12.03.20

According to melinda what are the pros and cons of Alexion Pharmaceutical Inc. for the foreseeable future?

Comments by melinda for this prediction

In the thread Alexion Pharmaceutical Inc. diskutieren

Published 29.09.18
Prediction Buy
Perf. (%) -43.827%
Target price 130.790
Change

SecteurProduits pharmaceutiques Agenda 02/10 | 16:00 Présentation



métier
Logo Alexion Pharmaceuticals
Alexion Pharmaceuticals is spécialisé in the recherche et le Développement de Produits Thérapeutiques au treatment des destins maladies Cardiovasculaires et hématologiques, des cancers maladies auto-immunes et Des.
A fin 2017, le groupe dispose d'un portefeuille DE 5 produits en développement clinique.
La répartition géographique du CA est la suivante: budget unique (43,9%), Europe (29,2%), Asie-Pacifique (9,8%) et autres (17,1%).

Nombre d'employés  : 2 525 personnes.



In the thread Trading Alexion Pharmaceutical Inc.

Published 12.03.20
Prediction Buy
Perf. (%) -43.827%
Target price 130.790
Change

Buy beendet

Current prediction by melinda for Alexion Pharmaceutical Inc.

Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€70.50
€95.00
36.766%

Stopped prediction by melinda for Alexion Pharmaceutical Inc.

Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€112.84
€153.34
-6.260%

Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€132.65
€175.89
-18.990%